Posted by Jo-Ana Chase (Methods Implementation Editor)
We seek nominations to two vacant positions on the Cochrane Methods Executive, to start in September 2025. Please note the deadline is *Monday 20 May 2025*.
What is the Methods Executive?
The Methods Executive provides a leadership forum and general oversight on key methodological roles and methods-related activity in Cochrane. Members take strategic responsibility supporting Cochrane’s Editor-in-Chief, representing Cochrane’s Methods Groups, and improving communication between different Cochrane groups and structures with related methods interests. Key responsibilities of the Methods Executive include:
- Act as a voice for the methods community within Cochrane, such as for Methods Groups, liaising with Cochrane Central Executive Team.
- Seek to ensure Cochrane is kept informed of important new methods (and improvements to existing methods) that should be considered for use in Cochrane.
- Oversee new methods proposals to Cochrane.
- Provide guidance and advice to the Editor in Chief and Editorial Board on devising and implementing strategies to improve the methodological quality of Cochrane Reviews and developing strategic methodological priorities in Cochrane.
- Provide strategic assistance in the management of methods development and training.
- Make decisions on methods-related activities in Cochrane, including the topic, organisation and delivery of the annual Methods Symposium.
- Oversee the Methods Groups.
- Promote Cochrane methods to the wider methods community and represent Cochrane externally on methodological issues or queries.
The Methods Executive is comprised of six elected Methods Group Convenors, which currently includes Tianjing Li (Comparing Multiple Interventions), Areti Veroniki (Statistics), Chantelle Garrity (Rapid Reviews), Carl Moons (Prognosis), Matt Page (Bias), and Evan Mayo-Wilson (Adverse Effects). Other roles on the Methods Executive include representation on Cochrane’s Editorial Board (currently Jane Noyes) and Cochrane Handbook Editor (currently Tianjing Li) and Editor of the Cochrane Evidence Synthesis and Methods journal (Michael Brown). The Methods Implementation Editor, Methods Support Unit Lead, Head of Editorial Policy and Research Integrity, and Head of Engagement, Learning, and Support serve in ex-officio roles. The Chairs of the Methods Executive are currently Tianjing Li and Areti Veroniki.
The Methods Executive has a standard tenure for elected Methods Group Convenors of three years, with annual nominations for vacancies each year. Once elected, Methods Group Convenors can remain in position for up-to a maximum of two tenures (six years). We are recruiting for two vacant positions.
Details of the open positions on the Methods Executive
The two open positions on the Methods Executive will fill vacancies from Tianjing Li (Comparing Multiple Interventions) and Carl Moons (Prognosis) who will rotate off at the end of 2025.
We seek two experienced, well-established Methods Group Convenors for appointment from September 2025. Candidates will have strong connections within the Cochrane community. Along with their specialist expertise they will be skilled in systematic review methodology, experience on similar committees is an advantage. Methods expertise from elected members of the Methods Executive currently covers Adverse Effects, Bias, Prognosis, Rapid Reviews, and Statistics. Therefore, we particularly encourage Convenors from other Methods Groups to step forward.
If elected, we expect members to attend meetings regularly, typically every two months by teleconference. We also expect contributions to issues that arise by e-mail between meetings.
Apply here